SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-009815
Filing Date
2020-05-07
Accepted
2020-05-07 16:07:05
Documents
69
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prog20200331_10q.htm 10-Q 1039388
2 EXHIBIT 31.1 ex_183905.htm EX-31.1 13010
3 EXHIBIT 32.1 ex_183906.htm EX-32.1 5769
  Complete submission text file 0001437749-20-009815.txt   5664466

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT pgnx-20200331.xml EX-101.INS 1309178
5 XBRL TAXONOMY EXTENSION SCHEMA pgnx-20200331.xsd EX-101.SCH 57982
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pgnx-20200331_cal.xml EX-101.CAL 41467
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pgnx-20200331_def.xml EX-101.DEF 347581
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pgnx-20200331_lab.xml EX-101.LAB 310982
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pgnx-20200331_pre.xml EX-101.PRE 382650
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Filer) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23143 | Film No.: 20856339
SIC: 2834 Pharmaceutical Preparations